These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1677885)

  • 1. H2 antagonist and omeprazole nonresponders.
    Savarino V; Mela GS; Vigneri S; Celle G
    Dig Dis Sci; 1991 Aug; 36(8):1172-3. PubMed ID: 1677885
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis comparing the efficacy of omeprazole with H2-receptor antagonists for acute treatment of duodenal ulcer in Asian patients.
    Bamberg P; Caswell CM; Frame MH; Lam SK; Wong EC
    J Gastroenterol Hepatol; 1992; 7(6):577-85. PubMed ID: 1362499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New antisecretory drugs in the treatment of ulcer].
    Sheptulin AA
    Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870
    [No Abstract]   [Full Text] [Related]  

  • 5. Omeprazole in H2 blocker non-responders.
    Savarino V; Mela G; Sumberaz A; Celle G
    Gut; 1990 May; 31(5):584. PubMed ID: 1972126
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of H2 blockers and omeprazole on peptic secretion: a prospective, randomized study in duodenal ulcer subjects.
    Di Mario F; Dotto P; Vianello F; Germanà B; Grassi SA; Del Favero G; Faggian D; Plebani M; Naccarato R
    Acta Gastroenterol Belg; 1993; 56(2):223-8. PubMed ID: 8103616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
    Rakov AL; Makarov IuS; Gorbakov VV; Mironenko DA; Golochalova TV
    Voen Med Zh; 2001 Sep; 322(9):54-8. PubMed ID: 11668793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peptic ulcer and drug therapy].
    Tsuneoka K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistant duodenal ulcer: when, why and what to do?
    Walt RP; Daneshmend TK
    Postgrad Med J; 1988 May; 64(751):369-72. PubMed ID: 2904675
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Difficult' duodenal ulcer patients: clinical and therapeutic problems.
    Bianchi Porro G; Parente F
    Dig Dis; 1991; 9(4):219-28. PubMed ID: 1680585
    [No Abstract]   [Full Text] [Related]  

  • 11. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
    Koop H; Koop I; Klein M; Stumpf M; Massarrat S; Arnold R
    J Clin Gastroenterol; 1989 Dec; 11(6):631-4. PubMed ID: 2573627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal ulcers that are difficult to heal.
    Pounder R
    BMJ; 1988 Dec; 297(6663):1560-1. PubMed ID: 2906259
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL; Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Refractory duodenal ulcer: an emerging therapeutic problem].
    Bianchi Porro G; Parente F
    Medicina (Firenze); 1988; 8(1):27-33. PubMed ID: 2906398
    [No Abstract]   [Full Text] [Related]  

  • 16. Omeprazole in the management of refractory duodenal ulcer.
    Bardhan KD
    Scand J Gastroenterol Suppl; 1989; 166():63-73. PubMed ID: 2574910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic tactics for treating patient with duodenal ulcer complicated my hemorrhage].
    Baskhaeva RG
    Eksp Klin Gastroenterol; 2003; (1):21-4, 181. PubMed ID: 12664778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The medical therapy of peptic ulcer. The state of the art].
    Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F
    Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic achlorhydria: for which diseases, when and for how long?].
    Koop H; Arnold R
    Dtsch Med Wochenschr; 1988 Mar; 113(13):516-8. PubMed ID: 2894969
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical utility and safety of omeprazole.
    Walan A
    Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.